Introduction
Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong performance of the bisphosphonate class.
Reasons to Purchase
*Understand current and future osteoporosis drug market dynamics
*Gain insight into the unmet needs of current osteoporosis treatment and to what extent pipeline drugs will address these issues
*Evaluate the sales forecasts of marketed, generic, and key pipeline drugs to 2018 in the US, Japan, France, Germany, Italy, Spain, and the UK
Other selected research from the 'Markets' category:
Biofuel Market Worldwide (2006)
The report "Biofuel Market Worldwide (2006)" provides an updated and detailed overview of the Biofuel market worldwide. It examines the emerging trends and provides exclusive forecasts, region wise snapshots of different product categories across the world. Learn More
Insomnia Market Forecast
The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis) in the US from April 2007 onwards has intensified competition for both existing and prospective players in the insomnia market... Learn More